Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents.

Estelrich J, Sánchez-Martín MJ, Busquets MA.

Int J Nanomedicine. 2015 Mar 6;10:1727-41. doi: 10.2147/IJN.S76501. eCollection 2015. Review.

2.

Molecular imaging of apoptosis: from micro to macro.

Zeng W, Wang X, Xu P, Liu G, Eden HS, Chen X.

Theranostics. 2015 Feb 20;5(6):559-82. doi: 10.7150/thno.11548. eCollection 2015. Review.

3.

Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine.

Winter PM, Pearce J, Chu Z, McPherson CM, Takigiku R, Lee JH, Qi X.

J Magn Reson Imaging. 2015 Apr;41(4):1079-87. doi: 10.1002/jmri.24654. Epub 2014 May 6.

4.

Facile and quantitative electrochemical detection of yeast cell apoptosis.

Yue Q, Xiong S, Cai D, Wu Z, Zhang X.

Sci Rep. 2014 Mar 14;4:4373. doi: 10.1038/srep04373.

5.

Membrane mimetic surface functionalization of nanoparticles: methods and applications.

Weingart J, Vabbilisetty P, Sun XL.

Adv Colloid Interface Sci. 2013 Sep;197-198:68-84. doi: 10.1016/j.cis.2013.04.003. Epub 2013 May 2. Review.

6.

Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality.

Cormode DP, Sanchez-Gaytan BL, Mieszawska AJ, Fayad ZA, Mulder WJ.

NMR Biomed. 2013 Jul;26(7):766-80. doi: 10.1002/nbm.2909. Epub 2013 Jan 10. Review.

7.

Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development.

Quillard T, Libby P.

Circ Res. 2012 Jul 6;111(2):231-44. doi: 10.1161/CIRCRESAHA.112.268144. Review.

8.

Structure - relaxivity relationships among targeted MR contrast agents.

Caravan P, Zhang Z.

Eur J Inorg Chem. 2012 Apr;2012(12):1916-1923.

9.

Hybrid nanoparticles for detection and treatment of cancer.

Sailor MJ, Park JH.

Adv Mater. 2012 Jul 24;24(28):3779-802. doi: 10.1002/adma.201200653. Epub 2012 May 21. Review.

10.

Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.

Waerzeggers Y, Monfared P, Viel T, Faust A, Kopka K, Schäfers M, Tavitian B, Winkeler A, Jacobs A.

Br J Radiol. 2011 Dec;84 Spec No 2:S168-78. doi: 10.1259/bjr/66405626. Review.

11.

Molecular magnetic resonance contrast agents for the detection of cancer: past and present.

Bogdanov A Jr, Mazzanti ML.

Semin Oncol. 2011 Feb;38(1):42-54. doi: 10.1053/j.seminoncol.2010.11.002. Review.

12.

Inorganic nanoparticle-based contrast agents for molecular imaging.

Cho EC, Glaus C, Chen J, Welch MJ, Xia Y.

Trends Mol Med. 2010 Dec;16(12):561-73. doi: 10.1016/j.molmed.2010.09.004. Epub 2010 Nov 10. Review.

13.

Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.

Chen W, Cormode DP, Fayad ZA, Mulder WJM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):146-161. doi: 10.1002/wnan.114. Epub 2010 Oct 21. Review.

14.

Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques.

van Tilborg GA, Vucic E, Strijkers GJ, Cormode DP, Mani V, Skajaa T, Reutelingsperger CP, Fayad ZA, Mulder WJ, Nicolay K.

Bioconjug Chem. 2010 Oct 20;21(10):1794-803. doi: 10.1021/bc100091q.

15.

Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers.

Sy JC, Davis ME.

J Cardiovasc Transl Res. 2010 Oct;3(5):461-8. doi: 10.1007/s12265-010-9210-x. Epub 2010 Jul 14. Review.

16.

Phosphatidylserine targeting for diagnosis and treatment of human diseases.

Schutters K, Reutelingsperger C.

Apoptosis. 2010 Sep;15(9):1072-82. doi: 10.1007/s10495-010-0503-y. Review.

17.

In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent.

Glaus C, Rossin R, Welch MJ, Bao G.

Bioconjug Chem. 2010 Apr 21;21(4):715-22. doi: 10.1021/bc900511j.

18.

High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.

Skajaa T, Cormode DP, Falk E, Mulder WJ, Fisher EA, Fayad ZA.

Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):169-76. doi: 10.1161/ATVBAHA.108.179275. Epub 2009 Oct 8. Review. Erratum in: Arterioscler Thromb Vasc Biol.2010 Sep;30(9):e176.

19.

Tyrosine polyethylene glycol (PEG)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque.

Beilvert A, Cormode DP, Chaubet F, Briley-Saebo KC, Mani V, Mulder WJ, Vucic E, Toussaint JF, Letourneur D, Fayad ZA.

Magn Reson Med. 2009 Nov;62(5):1195-201. doi: 10.1002/mrm.22103.

20.

Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging.

Mulder WJ, Strijkers GJ, van Tilborg GA, Cormode DP, Fayad ZA, Nicolay K.

Acc Chem Res. 2009 Jul 21;42(7):904-14. doi: 10.1021/ar800223c.

Supplemental Content

Support Center